Teva Wins Challenge To Novartis' Blood Transfusion Patent
Generic drug manufacturer Teva has succeeded in its bid to invalidate two patents owned by Novartis AG, as a London court found that the pharmaceutical giant's intellectual property for a blood...To view the full article, register now.
Already a subscriber? Click here to view full article